Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Sales (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Return on Sales data on record, last reported at 0.24% in Q4 2025.

  • For Q4 2025, Return on Sales rose 18.0% year-over-year to 0.24%; the TTM value through Dec 2025 reached 0.08%, up 8.0%, while the annual FY2025 figure was 0.08%, 8.0% up from the prior year.
  • Return on Sales reached 0.24% in Q4 2025 per ORGO's latest filing, up from 0.14% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.24% in Q4 2025 and bottomed at 0.22% in Q1 2025.
  • Average Return on Sales over 5 years is 0.04%, with a median of 0.05% recorded in 2023.
  • Peak YoY movement for Return on Sales: skyrocketed 36bps in 2021, then fell -20bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.15% in 2021, then tumbled by -56bps to 0.06% in 2022, then crashed by -78bps to 0.01% in 2023, then skyrocketed by 318bps to 0.06% in 2024, then skyrocketed by 289bps to 0.24% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.24% in Q4 2025, 0.14% in Q3 2025, and 0.09% in Q2 2025.